Where I see patients (1)
Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma.
A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
An AE is any untoward medical occurrence in a subject or clinical investigational subject administered a medicinal product and which does not necessarily have a causal relationship with this treatment.